Skip to main content
SpringerLink
Log in

FOLFIRINOX effektiver als Gemcitabin — auf Kosten hoher Toxizität

  • Journal Club / Pankreaskarzinom
  • Erstlinientherapie des metastasierten Pankreaskarzinoms
  • Published:
Info Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Hämato-Onkologische Gemeinschaftspraxis, München, Deutschland

    Erhard Hiller

Authors
  1. Erhard Hiller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Erhard Hiller.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hiller, E. FOLFIRINOX effektiver als Gemcitabin — auf Kosten hoher Toxizität. Info Onkol. 14, 26–27 (2011). https://doi.org/10.1007/BF03363036

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03363036

Schlüsselwörter

Search

Navigation